Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-12.08 Mil
% of Total Estimate Gain
-72.95%

Memorial Sloan Kettering Cancer Center's Caribou Biosciences Inc Holding Summary

As of 2023-09-30, Memorial Sloan Kettering Cancer Center held - shares of Caribou Biosciences Inc(CRBU), totaling N/A. This investment constitutes 0% of their stock portfolio, and Memorial Sloan Kettering Cancer Center now holds 0% of the outstanding Caribou Biosciences Inc(CRBU) stock.

The initial trade took place in 2021Q3. And since then Memorial Sloan Kettering Cancer Center has made 1 purchases of CRBU, at an average price of $24.56, for a total of 674,196.00 shares. In addition, there have been 3 sales at an average price of $6.64 for 674,196.00 shares. Based on historical transaction data and CRBU's current price of $1.32, Memorial Sloan Kettering Cancer Center's estimated gain on his CRBU holdings is $-12.08 Mil, reflecting a -72.95% gain to date.

Memorial Sloan Kettering Cancer Center CRBU ($1.32) Holding Chart

Memorial Sloan Kettering Cancer Center CRBU ($1.32) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1